Correction To: Secukinumab: A Review in Ankylosing Spondylitis

Drugs - United Kingdom
doi 10.1007/s40265-019-01089-x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

The Advent of IL-17A Blockade in Ankylosing Spondylitis: Secukinumab, Ixekizumab and Beyond

Expert Review of Clinical Immunology
AllergyImmunology
2019English

Relapsing Polychondritis Following Treatment With Secukinumab for Ankylosing Spondylitis: Case Report and Review of the Literature

Case Reports in Rheumatology
2018English

Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2019English

Ankylosing Spondylitis

2019English

Ankylosing Spondylitis

2019English

Correction To: Quantitative Metagenomics Reveals Unique Gut Microbiome Biomarkers in Ankylosing Spondylitis

Genome Biology
2017English

Ankylosing Spondylitis

2019English

Ankylosing Spondylitis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy